Lantern Pharma Inc.

SEC 4 · Filed

0001493152-25-028759Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Dec 18, 2025

Grant, award or other acquisition by Margrave David R.

Security
Stock Option (Right to Buy)
Code
A
Shares
20,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2025-12-18",
  "direction": "A",
  "exercise_price": "3.24",
  "expiration": "2035-12-17",
  "footnotes": {
    "F1": "The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026."
  },
  "owners": [
    {
      "cik": "0001813162",
      "name": "Margrave David R.",
      "roles": [
        "officer"
      ],
      "title": "Chief Financial Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "20000",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "20000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "20000"
}